Armistice Capital »

Acushnet Holdings Corp shares owned by Armistice Capital

Quarter-by-quarter ownership of Acushnet Holdings Corp (GOLF) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Acushnet Holdings Corp

Tip: Access up to 7 years of quarterly data

All positions including Acushnet Holdings Corp held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acushnet Holdings Corp by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $974k 18k 53.04

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Acushnet Holdings Corp

Vanguard Group
Wellington Management Company
Dimensional Fund Advisors
Jpmorgan Chase & Co
Wells Fargo & Company
Principal Financial Group
Raymond James & Associates
Charles Schwab Investment Management
Norges Bank Investment Management
Tributary Capital Management
D. E. Shaw & Co
Two Sigma Investments
Bank of New York Mellon
Two Sigma Advisers
Citadel Advisors

View all funds holding Acushnet Holdings Corp